Radiant Bio

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$35M

Radiant Biotherapeutics develops innovative therapies using its proprietary Multabody™ platform to target oncology, inflammation, immunology, and infectious diseases.